Equities research analysts expect M.D.C. Holdings, Inc. (NYSE:MDC) to post sales of $718.94 million for the current fiscal quarter, according to Zacks Investment Research. Four analysts have issued estimates for M.D.C.’s earnings, with the lowest sales estimate coming in at $706.00 million and the highest estimate coming in at $745.00 million. M.D.C. reported sales of $736.33 million in the same quarter last year, which indicates a negative year over year growth rate of 2.4%. The business is scheduled to report its next earnings report before the market opens on Thursday, February 1st.
According to Zacks, analysts expect that M.D.C. will report full-year sales of $718.94 million for the current financial year, with estimates ranging from $2.56 billion to $2.59 billion. For the next fiscal year, analysts anticipate that the firm will report sales of $2.83 billion per share, with estimates ranging from $2.71 billion to $2.96 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side analysts that cover M.D.C..
M.D.C. (NYSE:MDC) last issued its quarterly earnings results on Thursday, November 2nd. The construction company reported $1.16 earnings per share for the quarter, beating analysts’ consensus estimates of $0.61 by $0.55. The business had revenue of $586.30 million during the quarter, compared to analyst estimates of $595.05 million. M.D.C. had a net margin of 6.09% and a return on equity of 11.66%. M.D.C.’s revenue for the quarter was up 1.4% compared to the same quarter last year. During the same quarter last year, the business posted $0.54 earnings per share.
In other M.D.C. news, Director Herbert T. Buchwald sold 28,350 shares of the firm’s stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of $31.52, for a total value of $893,592.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director David Siegel sold 2,500 shares of the firm’s stock in a transaction that occurred on Friday, December 8th. The shares were sold at an average price of $31.83, for a total transaction of $79,575.00. The disclosure for this sale can be found here. 25.30% of the stock is currently owned by company insiders.
A number of hedge funds have recently made changes to their positions in MDC. Vanguard Group Inc. boosted its stake in M.D.C. by 14.8% in the second quarter. Vanguard Group Inc. now owns 4,347,875 shares of the construction company’s stock valued at $153,611,000 after acquiring an additional 561,481 shares during the last quarter. Koch Industries Inc. bought a new position in M.D.C. in the second quarter valued at approximately $342,000. JPMorgan Chase & Co. boosted its stake in M.D.C. by 120.9% in the third quarter. JPMorgan Chase & Co. now owns 547,871 shares of the construction company’s stock valued at $18,020,000 after acquiring an additional 299,904 shares during the last quarter. Prudential Financial Inc. boosted its stake in M.D.C. by 90.6% in the third quarter. Prudential Financial Inc. now owns 583,941 shares of the construction company’s stock valued at $19,393,000 after acquiring an additional 277,580 shares during the last quarter. Finally, Acadian Asset Management LLC boosted its stake in M.D.C. by 54.1% in the fourth quarter. Acadian Asset Management LLC now owns 443,507 shares of the construction company’s stock valued at $14,139,000 after acquiring an additional 155,618 shares during the last quarter. 73.12% of the stock is currently owned by hedge funds and other institutional investors.
Shares of M.D.C. (NYSE:MDC) opened at $34.13 on Monday. The company has a quick ratio of 2.60, a current ratio of 9.45 and a debt-to-equity ratio of 0.65. The firm has a market cap of $1,914.65, a P/E ratio of 12.25, a P/E/G ratio of 0.88 and a beta of 1.36. M.D.C. has a fifty-two week low of $23.95 and a fifty-two week high of $35.18.
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 21st. Shareholders of record on Wednesday, February 7th will be paid a $0.30 dividend. The ex-dividend date is Tuesday, February 6th. This is a boost from M.D.C.’s previous quarterly dividend of $0.25. This represents a $1.20 dividend on an annualized basis and a yield of 3.52%. M.D.C.’s dividend payout ratio (DPR) is presently 33.37%.
COPYRIGHT VIOLATION NOTICE: “M.D.C. Holdings, Inc. (MDC) Expected to Announce Quarterly Sales of $718.94 Million” was reported by American Banking News and is the property of of American Banking News. If you are reading this piece of content on another site, it was copied illegally and republished in violation of US & international copyright and trademark laws. The correct version of this piece of content can be viewed at https://www.americanbankingnews.com/2018/01/29/m-d-c-holdings-inc-mdc-expected-to-announce-quarterly-sales-of-718-94-million.html.
M.DC Holdings, Inc is engaged in two primary operations, including homebuilding and financial services. The Company’s segments include West, including segments located in Arizona, California, Nevada and Washington; Mountain, including segments located in Colorado and Utah; East, including segments located in Virginia, Florida and Maryland, which includes Pennsylvania and New Jersey; mortgage operations, including HomeAmerican Mortgage Corporation, and Other, which includes Allegiant Insurance Company, Inc, StarAmerican Insurance Ltd., American Home Insurance Agency, Inc and American Home Title and Escrow Company.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for M.D.C. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M.D.C. and related companies with MarketBeat.com's FREE daily email newsletter.